T1	Participants 23 74	patients treated for Helicobacter pylori infection.
T2	Participants 357 452	795 adults with preneoplastic gastric lesions was randomised to receive anti-H pylori treatment
T3	Participants 913 1017	Ninety seven per cent of subjects were H pylori positive at baseline, and 53% were positive at 12 years.
T4	Participants 1668 1711	patients with preneoplastic gastric lesions
